
Electrical fields designed to help the brain regain control of immune function by targeting neurological pathways.
Team
Nēsos was co founded by Konstantinos Alataris, Ph.D. and other neuroscientists that have successfully developed and commercialized electrical field treatments for neurological disorders. As the founder and former CEO of Nevro (NYSE: NVRO), Konstantinos led product development and the initial commercialization of Senza, Nevro's market-leading, implantable neuromodulator for the treatment of chronic pain. Nēsos is critically supported by expert clinical and scientific collaborators from leading academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University Of California, San Diego (UCSD), and the University Of California, San Francisco (UCSF).
Board
- Sunil Agarwal, MD Sana Biotechnology, Juno, Genentech
- Andre Walker Nevro, Abbott
- Ursheet Parikh Mayfield Fund
- Konstantinos Alataris, PhD. Nevro, Boston Scientific
Clinical Data
EULAR 2020 Poster
ACR 2020 Oral presentation by Matt Baker MD (Stanford)
Press
Connect
Nēsos aims to treat diseases, by restoring neurological pathways that control immune function. Using engineered electrical signals delivered by a noninvasive brain interface. Nēsos is guided and supported by clinical and scientific collaborators from top academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University of California, San Diego, and University of California, San Francisco. For more information, visit www.nesos.com.
© 2021 Nēsos Corp, All Rights Reserved